Chison Medical Technologies (688358.SH) plans to launch a restricted stock incentive plan in 2026.

Chison Medical Technologies (688358.SH) disclosed the 2026 Restricted Stock Incentive Plan (draft), under which the company plans to grant 497,500 restricted stocks to incentive recipients, accounting for approximately 0.44% of the total share capital of 112 million shares at the time of the announcement of the draft Incentive Plan. Of these, 398,000 shares will be granted initially, with 99,500 shares reserved. The grant price for the restricted stocks (including reserved shares) is 17.10 yuan per share. A total of 35 individuals will be initially granted incentives, accounting for about 7.49% of the total number of employees of the company as of December 31, 2025. The incentive recipients are employees of the company (including subsidiaries) deemed by the Board of Directors to be in need of motivation at the time of the announcement of the Incentive Plan, but excluding company directors, senior management, and core technical personnel.